Olaf Witt

Also affiliated with Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Hopp Children's Cancer Center Heidelberg, Deutsches Konsortium für Translationale Krebsforschung

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations”.

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

New England Journal of Medicine(2023)10.1056/nejmoa2303815

N/A

0.846DataRank · unranked

281 citations

Jordan R. Hansford, Maria Luisa Garrè, Junichi Hara, Ashley Plant-Fox, Isabelle Aerts +13 more

Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors

ChemMedChem(2020)10.1002/cmdc.202000149

N/A

0DataRank · unranked

38 citations

Raphael R. Steimbach, Magalie Géraldy, Lars Hellweg, Peter Sehr, Johannes Ridinger +9 more